Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Landos Biopharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 40 | +5 |
| Shares | 22.7M | 24.9M | +2.27M (+10.0%) |
| Value | $331.1M | $119.8M | −$211.3M (−63.8%) |
New holders (11)
Institutions that held Landos Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $8.77M | 3.95% |
| Walleye Capital LLC | 105,208 | $505.0K | 0.02% |
| Two Sigma Investments, LP | 54,778 | $263.0K | 0.00% |
| Walleye Trading LLC | 43,279 | $208.0K | 0.00% |
| Two Sigma Advisers, LP | 25,700 | $123.0K | 0.00% |
| Goldman Sachs Group Inc | 17,568 | $84.0K | 0.00% |
| Jump Financial, LLC | 15,200 | $73.0K | 0.00% |
| Acadian Asset Management LLC | 8,274 | $39.0K | 0.00% |
| UBS Group AG | 3,805 | $18.0K | 0.00% |
| Manchester Capital Management LLC | 406 | $2.00K | 0.00% |
| Wells Fargo & Company | 14 | $0 | 0.00% |
Sold out (6)
Institutions that held Landos Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Woodline Partners LP | 212,800 | $3.11M |
| Ensign Peak Advisors, Inc | 125,000 | $1.82M |
| Cambridge Investment Research Advisors, Inc. | 18,831 | $275.0K |
| Jacobs Levy Equity Management, Inc | 18,174 | $265.0K |
| Geneos Wealth Management Inc. | 1,100 | $16.0K |
| Cahill Financial Advisors Inc | 100 | $1.00K |